A Prospective Cohort Study of Primary Dengue Virus Infection in Medellín, Colombia
This study identified a cohort of predominantly students, seronegative at study start, living in Medellín and serving as a proxy for a prospective DENV infection traveler population. Laboratory-confirmed primary DENV infection was found in 2% of participants, with <1% reporting febrile illnesses, meeting the WHO criteria for probable clinical dengue cases.
Authors
- Liliana López (ORCID: https://orcid.org/0000-0003-1912-0996)
- Liesbeth Van Wesenbeeck (ORCID: https://orcid.org/0000-0002-1760-9854)
- Guillermo Herrera‐Taracena
- Leen Vijgen (ORCID: https://orcid.org/0000-0002-4356-2199)
- Lotke Tambuyzer (ORCID: https://orcid.org/0000-0002-1705-3753)
- Oliver Lenz
- Iván Darío Vélez (ORCID: https://orcid.org/0000-0003-2227-4662)
- Marnix Van Loock (ORCID: https://orcid.org/0000-0003-4151-4588)
- Lina María Salazar-Peláez (ORCID: https://orcid.org/0000-0001-6224-1078)
- Annemie Buelens (ORCID: https://orcid.org/0009-0002-0216-348X)
- Andrea Trujillo (ORCID: https://orcid.org/0000-0001-6474-4904)
- Kim De Clerck
- Freya Rasschaert (ORCID: https://orcid.org/0000-0003-0943-5599)
Institutions
- Johnson & Johnson (United States) (US)
- Universidad de Antioquia (CO)
Publication Details
- Journal
- Vaccines
- Published
- 2025-07-12
- DOI
- https://doi.org/10.3390/vaccines13070748
- Primary Topic
- Mosquito-borne diseases and control
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Johnson and Johnson